Table 2.

Clinical features of GATA2 deficiency syndrome

Clinical featurePercentage of patients
Hematologic  
 Cytopenias  
  B cell 86 
  NK cell 82 
  Monocytopenia 78 
  CD4 51 
  Neutropenia 47 
 Malignant blood disorders  
  MDS* 84 
  AML 14 
  CMML 
Infectious  
 Viral 70 
  HPV 63 
  Herpesvirus 35 
   Herpes simplex virus 16 
   Varicella Zoster virus 11 
   EBV 11 
   Cytomegalovirus 
   Molloscum contagiosum 3.5 
 Bacterial  
  Disseminated nontubercular mycobacteria 53 
  Other severe bacterial 49 
  Severe fungal 16 
   Aspergillosis 
   Histoplasmosis 
   Candidiasis 
Solid tumors  
 HPV-related neoplasia 35 
 EBV-related neoplasia  
 Breast cancer§ 22 
Pulmonary  
 Pulmonary alveolar proteinosis 18 
 Pulmonary function test abnormalities 79 
Lymphedema 11 
Venous thrombosis 25 
Mild to severe sensorineuronal hearing loss|| 76 
Miscarriage 33 
Hypothyroidism 14 
Clinical featurePercentage of patients
Hematologic  
 Cytopenias  
  B cell 86 
  NK cell 82 
  Monocytopenia 78 
  CD4 51 
  Neutropenia 47 
 Malignant blood disorders  
  MDS* 84 
  AML 14 
  CMML 
Infectious  
 Viral 70 
  HPV 63 
  Herpesvirus 35 
   Herpes simplex virus 16 
   Varicella Zoster virus 11 
   EBV 11 
   Cytomegalovirus 
   Molloscum contagiosum 3.5 
 Bacterial  
  Disseminated nontubercular mycobacteria 53 
  Other severe bacterial 49 
  Severe fungal 16 
   Aspergillosis 
   Histoplasmosis 
   Candidiasis 
Solid tumors  
 HPV-related neoplasia 35 
 EBV-related neoplasia  
 Breast cancer§ 22 
Pulmonary  
 Pulmonary alveolar proteinosis 18 
 Pulmonary function test abnormalities 79 
Lymphedema 11 
Venous thrombosis 25 
Mild to severe sensorineuronal hearing loss|| 76 
Miscarriage 33 
Hypothyroidism 14 

Percentage of patients manifesting noted clinical features. Data abstracted from Spinner et al95  from 57 patients, 40 of whom were diagnosed on the basis of clinical presentation, with an additional 17 through family screening. Similar data are tabulated by Collin et al.

CMML, chronic myelomonocytic leukemia; EBV, Epstein-Barr virus; HPV, human papillomavirus.

*

Of 50 patients who underwent bone marrow biopsy.

Reflects potential ascertainment bias before clinical phenotype expanded.

Per Cohen et al.92 

§

Of 18 women ≥35 years old, including one with a concurrent BRCA2 mutation.

||

Not controlled for aminoglycoside exposure for treatment of bacterial infections.

Of 43 known pregnancies.

or Create an Account

Close Modal
Close Modal